
Schelling Pharma Private Limited
About Schelling Pharma Private Limited
Data last updated:
Schelling Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 19 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U51909RJ2019PTC064320. Its GSTIN is 08ABBCS7693A1Z8 (Rajasthan).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Hem Lata Phoolia and Ved Prakash Ahuja.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 121 First Floor City Plaza Jhotwara Road, Jaipur, Rajasthan, India – 302016.
As per the financials filed for FY 2023, the company reported a revenue of ₹21.72 Lakh, a decline of 39% compared to the previous year. For the same year it recorded a net profit of ₹4,206 (net margin 0.2%) and EBITDA of ₹40,985 (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years.
Company details
Contact details
Schelling Pharma Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address is in the company report.
- Email
- Registered Address121 First Floor City Plaza Jhotwara Road, Jaipur, Rajasthan, India – 302016
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Schelling Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Schelling Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Schelling Pharma Private Limited, buy the company report.
Financials of Schelling Pharma Private Limited
FY 2023 filings availableSchelling Pharma Private Limited reported revenue of ₹21.72 Lakh (down 39% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 39% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 28%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹40,985 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,206 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Schelling Pharma Private Limited, buy the company report.
Board of directors of Schelling Pharma Private Limited
Schelling Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hem Lata Phoolia | Director | 19 Mar 2019 | 7 Years 8 Months | Current |
| Ved Prakash Ahuja | Director | 19 Mar 2019 | 7 Years 8 Months | Current |
| Naresh Kumar Anand | Director | 19 Mar 2019 | 7 Years 8 Months | Current |
Peer comparison
Schelling Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Opti India Pharma Private Limited | ₹21.81 Lakh (FY 2025) | 432.0% | Mumbai, Maharashtra, India | |||
| Herbs Era Pharmaceuticals Pvt Ltd | ₹21.81 Lakh (FY 2025) | -28.0% | Madhyamgram, West Bengal, India | |||
| Amnium Technologies Private Limited | ₹21.79 Lakh (FY 2023) | 23.0% | Pune, Maharashtra, India | |||
| Parsit Agarbatti Works Private Limited | ₹21.73 Lakh (FY 2016) | -26.0% | Ahmedabad, Gujarat, India | |||
| Nirma Industries Private Limited | ₹21.73 Lakh (FY 2024) | -94.0% | Ahmedabad, Gujarat, India | |||
| Schelling Pharma Private Limitedthis company | ₹21.72 Lakh (FY 2023) | ₹4,206 | 0.2% | -39.0% | Jaipur, Rajasthan, India | |
| Vaaman Laboratories Private Limited | ₹21.72 Lakh (FY 2024) | -78.0% | Hyderabad, Telangana, India | |||
| Rithika Pharmaceuticals Private Limited | ₹21.68 Lakh (FY 2019) | Telangana, India | ||||
| Popular Biotech Private Limited | ₹21.67 Lakh (FY 2022) | 59.0% | Delhi, India | |||
| Zum Heilen Diagnostic and Therapeutics Private Limited | ₹21.66 Lakh (FY 2024) | 158.0% | Udumbanchola, Kerala, India | |||
| Gipsar Speciality Chemicals Private Limited | ₹21.65 Lakh (FY 2023) | Thane, Maharashtra, India |
To see the full peer comparison of Schelling Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Schelling Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Schelling Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Schelling Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08ABBCS7693A1Z8 | Rajasthan | Active | 03 May 2019 |
To see the full GST registrations and return filing status of Schelling Pharma Private Limited, buy the company report.
Recent activity
Schelling Pharma Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Hem Lata Phoolia was appointed as Director on 19 Mar 2019.
Frequently asked questions
Schelling Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in specialty, within the trading industry. It was incorporated on 19 March 2019 (7+ years old) and is registered under CIN U51909RJ2019PTC064320.
Schelling Pharma has 3 current directors:
- Hem Lata Phoolia - Director
- Ved Prakash Ahuja - Director
- Naresh Kumar Anand - Director
The latest financial statements of Schelling Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Schelling Pharma is 08ABBCS7693A1Z8, registered in Rajasthan.
The CIN (Corporate Identification Number) of Schelling Pharma is U51909RJ2019PTC064320. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Schelling Pharma was incorporated on 19 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Schelling Pharma by revenue are Opti India Pharma Private Limited, Herbs Era Pharmaceuticals Pvt Ltd, Amnium Technologies Private Limited, Parsit Agarbatti Works Private Limited, Nirma Industries Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Hem Lata Phoolia was appointed as Director on 19 Mar 2019. Naresh Kumar Anand was appointed as Director on 19 Mar 2019. Ved Prakash Ahuja was appointed as Director on 19 Mar 2019.
The registered office of Schelling Pharma is at 121 First Floor City Plaza Jhotwara Road, Jaipur, Rajasthan, India – 302016.
Schelling Pharma operates in the trading industry, in the specialty segment.
Schelling Pharma can be reached at its registered office: 121 First Floor City Plaza Jhotwara Road, Jaipur, Rajasthan, India – 302016.

